Сourse features of a new coronavirus infection in a comorbid patient

Abstract

The appearance of a new coronavirus infection (COVID-19) in 2020 caused by the SARS-CoV-2 virus set tasks for doctors of various specialties to quickly diagnose, treat, and develop effective rehabilitation measures. The medical community’s knowledge about the respiratory tract lesions pathogenesis course in COVID-19 is going to improve, but the key accents placement in understanding this pathology course continues today. Suspected SARS-CoV-2 virus reference points are as follows: vascular endothelial dysfunction, coagulopathy, thrombosis resembling the antiphospholipid syndrome. Treatment is carried out in accordance with general recommendations aimed at the average patient despite the higher secondary infectious complications risk in patients suffering from cancer and a high severe COVID-19 risk. A successful inpatient treatment experience in patients suffering from comorbid pulmonary pathology and a new coronavirus infection is demonstrated on a separate example. The treatment duration and the complexity of selecting a rehabilitation measures course were due to the patient's history of central squamous cell lung cancer, surgical intervention (bilobectomy), radio- and chemotherapy, as well as complications in the form of pulmonary embolism. The concomitant respiratory pathology was differentiated (chronic obstructive pulmonary disease) during examination and treatment and basic therapy was selected, which made the medical rehabilitation stage more effective. The patient's condition required a more careful selection of combined anti-inflammatory, broncholytic, mucolytic, and antibacterial therapy than in patients without concomitant pathology. Treatment and a complex of rehabilitation measures, normalization of respiratory function, compensation for concomitant bronchopulmonary pathology was possible to be achieves as a result of the diagnosis of concomitant bronchopulmonary pathology. Careful diagnostic search and optimal treatment of all somatic pathology are important factors in the selection of adequate therapy for elderly patients suffering from coronavirus infection with comorbid pulmonary pathology.

Keywords

new coronavirus infection / lung cancer / smoking / d-dimer / pulmonary arthery embolism / computed tomography / chronic obstructive lung desease / bronchodilator / rehabilitation

References

[1] Zaykovskaya AV, Gladysheva AV, Kartashov MYu, et al. In vitro study of Biological Properties of SARS-CoV-2 Coronavirus Strains Related to Various Genetic Variants. Problems of Particularly Dangerous Infections. 2022;(1):94–100. (In Russ.). DOI: 10.21055/0370-1069-2022-1-94-100

[2] Зайковская А.В., Гладышева А.В., Карташов М.Ю., и др. Изучение в условиях in vitro биологических свойств штаммов коронавируса SARS-CoV-2, относящихся к различным генетическим вариантам // Проблемы особо опасных инфекций. 2022. № 1. С. 94–100. DOI: 10.21055/0370-1069-2022-1-94-100

[3] Gavrilov DV, Kirilkina AV, Serova LM. Algorithm for forming a suspicion of a new coronavirus infection based on the analysis of symptoms for use in medical decision support systems. Medical Doctor and IT. 2020;(4):51–58. (In Russ.). DOI: 10.37690/1811-0193-2020-4-51-58

[4] Гаврилов Д.В., Кирилкина А.В., Серова Л.М. Алгоритм формирования подозрения на новую коронавирусную инфекцию на основе анализа симптомов для использования в системах поддержки принятия врачебных решений // Врач и информационные технологии. 2020. № 4. С. 51–58. DOI: 10.37690/1811-0193-2020-4-51-58

[5] Kryukov EV, Trishkin DV, Salukhov VV, et al. A Prospective Multicenter Randomized Study State of Humoral Immunity after a New Coronavirus Infection (COVID-19) of a Mild or Asymptomatic Course. Annals of the Russian Academy of Medical Sciences. 2021;76(4):361–367. (In Russ.). DOI: 10.15690/vramn1582

[6] Крюков Е.В., Тришкин Д.В., Салухов В.В., и др. Особенности формирования и продолжительность сохранения нейтрализующих антител к S-белку SARS-CoV-2 у лиц, перенесших новую коронавирусную инфекцию (COVID-19) легкого или бессимптомного течения // Вестник Российской академии медицинских наук. 2021. Т. 76, № 4. С. 361–367. DOI: 10.15690/vramn1582

[7] Zhdanov KV, Kozlov KV, Bulankov YI, et al. Optimization of diagnosis of SARS-CoV-2 infection using polymerase chain reaction in a large multi-specialty hospital. Bulletin of the Russian Military Medical Academy. 2020;70(2):7–10. (In Russ.). DOI:10.17816/brmma.02

[8] Жданов К.В., Козлов К.В., Буланьков Ю.И., и др. Оптимизация диагностики инфекции, вызванной SARS-CoV-2, с использованием полимеразной цепной реакции в крупном многопрофильном стационаре // Вестник Российской военно-медицинской академии. 2020. Т. 70, № 2. С. 7–10. DOI:10.17816/brmma.02

[9] Kryukov EV, Trishkin DV, Ivanov AM, et al. Comparative Cohort Epidemiological Study of Collective Immunity against New Coronavirus Infection among Different Groups of Military Personnel. Annals of the Russian Academy of Medical Sciences. 2021;76(6): 661–668. (In Russ.). DOI: 10.15690/vramn1583

[10] Крюков Е.В., Тришкин Д.В., Иванов А.М., и др. Эпидемиологическое исследование коллективного иммунитета против новой коронавирусной инфекции среди разных групп военнослужащих // Вестник Российской академии медицинских наук. 2021. Т. 76, № 6. C. 661–668. DOI: 10.15690/vramn1583

[11] Kryukov EV, Shulenin KS, Cherkashin DV, et al. Patogenez i klinicheskie proyavleniya porazheniya serdechno-sosudistoi sistemy u patsientov s novoi koronavirusnoi infektsiei (COVID–19): uchebnoe posobie. Saint Petersburg: Veda Print, 2021. 36 p. (In Russ.).

[12] Крюков Е.В., Шуленин К.С., Черкашин Д.В., и др. Патогенез и клинические проявления поражения сердечно-сосудистой системы у пациентов с новой коронавирусной инфекцией (COVID–19): учебное пособие. Санкт-Петербург: Веда Принт, 2021. 36 с.

[13] Ivchenko EV, Kotiv BN, Ovchinnikov DV, Bucenko SA. Results of the work of the Military Medical Academy Research Institute of novel coronavirus infection problems through 2020–2021. Bulletin of the Russian Military Medical Academy. 2021;23(4):93–104. (In Russ.). DOI: 10.17816/brmma83094

[14] Ивченко Е.В., Котив Б.Н., Овчинников Д.В., Буценко С.А. Результаты работы научно-исследовательского института проблем новой коронавирусной инфекции Военно-медицинской академии за 2020–2021 гг. // Вестник Российской военно-медицинской академии. 2021. Т. 23, № 4. C. 93–104. DOI: 10.17816/brmma83094

[15] Salukhov VV, Kryukov EV, Chugunov AA, et al. The role and place of glucocorticosteroids in treatment of COVID-19 pneumonia without hypoxemia. Medical Council. 2021;(12):162–172. (In Russ.). DOI: 10.21518/2079-701X-2021-12-162-172

[16] Салухов В.В., Крюков Е.В., Чугунов А.А., и др. Роль и место глюкокортикостероидов в терапии пневмоний, вызванных COVID-19, без гипоксемии // Медицинский совет. 2021. № 12. С. 162–172. DOI: 10.21518/2079-701X-2021-12-162-172

[17] Trishkin DV, Kryukov EV, Frolov DV, et al. Physical rehabilitation of patients with a new coronavirus infection SARS-CoV-2 (COVID-19) in a hospital. Russian Military Medical Journal. 2020;341(9):13–19. (In Russ.). DOI: 10.17816/RMMJ82354

[18] Тришкин Д.В., Крюков Е.В., Фролов Д.В., и др. Физическая реабилитация пациентов с новой коронавирусной инфекцией SARS-CoV-2 (COVID-19) в стационаре // Военно-медицинский журнал. 2020. Т. 341, № 9. С. 13–19. DOI: 10.17816/RMMJ82354

RIGHTS & PERMISSIONS

Eco-Vector